Department of Health

The National Blood Authority (NBA) manages the appropriate use of Immunoglobulin (Ig) in Australia in accordance with the approved indications set out in the Criteria for the clinical use of immunoglobulin in Australia.

This is applicable for both intravenous (IV) and subcutaneous (SC) immunoglobulins.

Online resource - Criteria for the clinical use of immunoglobulin in Australia

The Criteria for immunoglobulin use in AustraliaExternal Link is available on the National Blood Authority website.

The National Blood Authority has introduced this supply and governance structure to address the continued growth in demand for IVIg. It aims to ensure equity and sustainability of this resource.

Immunoglobulin safety notice

There is a potential for issuing and administration errors due to the new look-alike, sound-alike IVIg and SCIg products.

Download the safety alert for more information or to distribute to relevant areas.

Reviewed 22 November 2023


Contact us

Blood Matters Program Australian Red Cross Lifeblood

Was this page helpful?